ARTV vs AZO · $37.3M cap vs P/E 21, rev $18.94B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
ARTV currently screens at market cap $37.3M. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the ARTV and AZO stock pages for the full models.
Not investment advice.